Medication Guide Reading Behaviors and Attitudes Among Subjects With Migraine, Asthma, or COPD

• Published in: Therapeutic innovation & regulatory science Vol. 49; no. 3; pp. 377 - 386
• Main Authors: Bibeau, Kristen B., DiSantostefano, Rachael L., Hinds, David
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.05.2015; Springer International Publishing; Springer Nature B.V
• Subjects: Asthma; Authorship; Chronic obstructive pulmonary disease; Drug Safety and Pharmacovigilance; Drug stores; Headaches; Migraine; Patients; Pharmaceutical industry; Pharmacotherapy; Pharmacy; Policy: Original Research; Prescription drugs; Printed materials; Questionnaires; Studies; United States > US; survey; medication; Treximet; Advair; safety
• ISSN: 2168-4790; 2168-4804
• DOI: 10.1177/2168479014561802

Background: This cross-sectional survey describes attitudes and reading behaviors toward medication guides among 785 subjects with migraine, asthma, or COPD who reported recent use of Treximet (sumatriptan/naproxen sodium) or Advair (fluticasone propionate/salmeterol). Results: The survey demonstrated that the majority (82%) of subjects had read their medication guide, but most read it exactly once and did not read it thoroughly. Patients did not read medication guides with each refill, with the most frequent reasons being that they did not expect the information to have changed and that a doctor would tell them what they needed to know. Factors significantly associated with patients hypothetically being more likely to read medication guides associated with their new prescription included increasing age, simplification to format and content of the medication guide, and where subjects typically received their medication safety information. Patients reported acquiring medication safety from doctors or pharmacists more frequently than from medication guides. Conclusions: The results provide insights into potential revisions to the medication guides that may improve reading behaviors.